- Ticker
- AADI
- Price
- 5.13
- Stock movement down
- -0.09 (-1.72%)
- Company name
- Aadi Bioscience Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markedsværdi
- 125.15M
- Ent værdi
- 15.33M
- Pris/omsætning
- 11.39
- Pris/bog
- 0.74
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -4.62%
- Efterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års afkast
- -60.75%
- 3 års afkast
- -73.46%
- 5 års afkast
- -63.14%
- 10 års afkast
- -
Senest opdateret: 2023-09-08
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - SVP of IR and Corporate CommunicationsScott...
9. august 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
9. august 2023
iO Charts is a Seeking Alpha partner
UDBYTTE
AADI betaler ikke udbytte
Loading...
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 11.39 |
| Pris til egenkapital | 0.74 |
| EV i forhold til salg | 1.39 |
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
8. august 2023
iO Charts is a Seeking Alpha partner
Aadi Biosciences is focused on developing and commercializing precision therapies for genetically defined cancers. Find out my rating for AADI stock here.
29. juni 2023
iO Charts is a Seeking Alpha partner
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 24.40M |
| EPS (TTM) | -2.94 |
| FCF pr. aktie (TTM) | -3.84 |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | 10.99M |
| Bruttofortjeneste (TTM) | 10.00M |
| Driftsindkomst (TTM) | -63.16M |
| Nettoindkomst (TTM) | -62.59M |
| EPS (TTM) | -2.94 |
| EPS (1 år frem) | -2.53 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | 90.96% |
| Driftsmargin (TTM) | -574.71% |
| Fortjenstmargin (TTM) | -569.57% |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 134.81M |
| Nettotilgodehavender | 2.26M |
| Omsætningsaktiver i alt | 189.86M |
| Goodwill | 0.00 |
| Immaterielle aktiver | 0.00 |
| Ejendomme, anlæg og udstyr | 0.00 |
| Sum aktiver | 194.10M |
| Kreditor | 3.92M |
| Kortfristet/nuværende langsigtet gæld | 1.72M |
| Summen af kortfristede forpligtelser | 17.89M |
| Sum gæld | 25.00M |
| Aktionærernes egenkapital | 169.11M |
| Materielle nettoaktiver | 169.11M |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | -80.89M |
| Investeringsudgifter (TTM) | 676.00K |
| Fri pengestrøm (TTM) | -81.57M |
| Udbetalt udbytte (TTM) | 3.77M |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | -37.01% |
| Afkast af aktiver | -32.25% |
| Afkast af investeret kapital | -36.93% |
| Kontant afkast af investeret kapital | -48.13% |
Loading...
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 5.27 |
| Daglig høj | 5.28 |
| Daglig lav | 5.06 |
| Daglig volumen | 97K |
| Højeste gennem alle tider | 1485.00 |
| 1 års analytiker estimat | 42.50 |
| Beta | - |
| EPS (TTM) | -2.94 |
| Udbytte pr. aktie | - |
| Ex-div dato | - |
| Næste dato for resultatpræsentation | 7 Nov 2023 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| AADI | S&P500 | |
| Nuværende prisfald fra top notering | -99.65% | -6.74% |
| Højeste prisfald | -99.65% | -56.47% |
| Højeste efterår dato | 8 Sep 2023 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -78.10% | -11.49% |
| Gennemsnitlig tid til nyt højdepunkt | 78 days | 13 days |
| Maks. tid til nyt højdepunkt | 1454 days | 1805 days |
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations and...
10. maj 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
10. maj 2023
iO Charts is a Seeking Alpha partner
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
125.15M
Markedsværdi kategori
Small-cap
Beskrivelse
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Personale
76
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
USA
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
9. maj 2023
iO Charts is a Seeking Alpha partner
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q4 2022 Earnings Conference Call March 28, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations and...
28. marts 2023
iO Charts is a Seeking Alpha partner
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Seeking AlphaPressemeddelelser
The following slide deck was published by Aadi Bioscience, Inc.
28. marts 2023
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
28. marts 2023
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
27. marts 2023
Aadi Bioscience is a commercial stage company with a potential label expansion ahead. Click here to learn why I rate AADI stock a Buy.
7. marts 2023
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
3. marts 2023
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations &...
9. november 2022
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
9. november 2022
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
8. november 2022
The following slide deck was published by Aadi Bioscience, Inc.
3. november 2022
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
12. oktober 2022
iO Charts is a Seeking Alpha partnerNæste side